Funding Strategy
In 1993, PCF created a Competitive Awards program that revolutionized the evaluation and funding of prostate cancer research. Fortune magazine credited PCF with creating the “modern venture philanthropy” model for cancer research—citing the transformative power of...
The 2018 Patient Guide is here
Enter your email address to get the free pdf
What This Means for Science and Patients: This proposed Challenge Award’s findings will translate directly to patients survivability, facilitating an improved standard of care and solidifying the next level of...
Download our Guides
PCF publishes a series of helpful guides as part of our commitment to connect men and their loved ones to the latest prostate cancer research information. You can order or download these guides here.
DownloadPCF Funded Studies That May Impact Your Practice
2017 ASCO Meeting: Results from the LATITUDE Study
If you have just been diagnosed with metastatic prostate cancer and your doctor wants to start you on ADT (androgen deprivation therapy, such as Lupron), which shuts off the supply of testosterone and other male hormones,...
Read More
Roswell Park Research Helps Explain Why Androgen-Deprivation Therapy Doesn’t Work for Many Prostate Cancers
BUFFALO, N.Y. (Roswell Park Cancer Institute) — Metastatic prostate cancer, or prostate cancer that has spread to other organs, is incurable. In new research published in the journal Science, Roswell Park Cancer Institute scientists have identified...
Read More
New study finds one in nine men with metastatic prostate cancer carry inherited mutations in DNA repair genes with important implications for treatment and for cancer risk in family members
https://www.youtube.com/embed/8pjv5M7G58U Cancer, the uncontrolled growth of cells, is caused by the acquisition of genetic mutations that allow cells to evade the normal biological laws governing when and where they can grow in the body. Mechanisms that...
Read More
New Genetic Test Helps To Select Best Medicines For Prostate Cancer Treatment And Identifies Hereditary Cancer Genes
Like self-driving cars, precision medicine for prostate cancer is no promise of the distant future -- with the efforts of Prostate Cancer Foundation (PCF)-funded researchers and others, the prototypes have arrived. The first major precision medicine...
Read More